Pro Share Advisors LLC Biogen Inc. Transaction History

Pro Share Advisors LLC

$36.5 Billion
Q2 2024

A detailed history of Pro Share Advisors LLC transactions in Biogen Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 157,628 shares of BIIB stock, worth $27.4 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

157,628

Previous 174,000 9.41%

Holding current value

$27.4 Million

Previous $37.5 Million 2.61%

% of portfolio

0.1%

Previous 0.1%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$190.52 - $236.72 $3.12 Million - $3.88 Million	-16,372 Reduced 9.41%	157,628 $36.5 Million
Q1 2024 May 08, 2024	BUY	$212.02 - $267.71 $6.34 Million - $8 Million	29,890 Added 20.74%	174,000 $37.5 Million
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $5.41 Million - $6.51 Million	-24,291 Reduced 14.42%	144,110 $37.3 Million
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $4.76 Million - $5.38 Million	18,807 Added 12.57%	168,401 $43.3 Million
Q2 2023 Aug 10, 2023	SELL	$275.25 - $318.06 $2.29 Million - $2.65 Million	-8,329 Reduced 5.27%	149,594 $42.6 Million
Q1 2023 May 11, 2023	BUY	$256.56 - $292.34 $4.19 Million - $4.78 Million	16,349 Added 11.55%	157,923 $43.9 Million
Q4 2022 Feb 02, 2023	SELL	$252.44 - $306.72 $3.7 Million - $4.5 Million	-14,664 Reduced 9.39%	141,574 $39.2 Million
Q3 2022 Nov 04, 2022	SELL	$194.69 - $268.46 $6.12 Million - $8.44 Million	-31,426 Reduced 16.75%	156,238 $41.7 Million
Q2 2022 Aug 01, 2022	SELL	$187.54 - $223.02 $17.5 Million - $20.8 Million	-93,184 Reduced 33.18%	187,664 $38.3 Million
Q1 2022 May 10, 2022	SELL	$193.77 - $244.14 $2.87 Million - $3.62 Million	-14,834 Reduced 5.02%	280,848 $59.1 Million
Q4 2021 Feb 08, 2022	BUY	$223.92 - $287.77 $18.3 Million - $23.5 Million	81,691 Added 38.17%	295,682 $70.9 Million
Q3 2021 Nov 12, 2021	BUY	$282.99 - $369.05 $5.87 Million - $7.65 Million	20,728 Added 10.73%	213,991 $60.6 Million
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $2.08 Million - $3.32 Million	-8,014 Reduced 3.98%	193,263 $66.9 Million
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $5.67 Million - $6.64 Million	23,338 Added 13.12%	201,277 $56.3 Million
Q4 2020 Feb 09, 2021	BUY	$236.26 - $355.63 $4.91 Million - $7.39 Million	20,770 Added 13.22%	177,939 $43.6 Million
Q3 2020 Nov 13, 2020	BUY	$264.77 - $305.71 $4.92 Million - $5.68 Million	18,580 Added 13.41%	157,169 $44.6 Million
Q2 2020 Aug 03, 2020	SELL	$258.66 - $342.55 $105,533 - $139,760	-408 Reduced 0.29%	138,589 $37.1 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $16.5 Million - $20.9 Million	-61,284 Reduced 30.6%	138,997 $44 Million
Q4 2019 Feb 12, 2020	BUY	$220.06 - $304.07 $4.52 Million - $6.25 Million	20,543 Added 11.43%	200,281 $59.4 Million
Q3 2019 Nov 12, 2019	SELL	$217.44 - $243.88 $548,166 - $614,821	-2,521 Reduced 1.38%	179,738 $41.8 Million
Q2 2019 Aug 13, 2019	SELL	$219.29 - $241.72 $7.87 Million - $8.68 Million	-35,890 Reduced 16.45%	182,259 $42.6 Million
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $140,428 - $219,646	-648 Reduced 0.3%	218,149 $51.6 Million
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $5.6 Million - $7.09 Million	20,103 Added 10.12%	218,797 $65.8 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $9.43 Million - $12.3 Million	-32,114 Reduced 13.91%	198,694 $70.2 Million
Q2 2018 Aug 13, 2018	SELL	$257.52 - $306.91 $5.97 Million - $7.12 Million	-23,191 Reduced 9.13%	230,808 $67 Million
Q1 2018 May 14, 2018	BUY	$260.13 - $367.91 $8.42 Million - $11.9 Million	32,376 Added 14.61%	253,999 $69.6 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $10.2 Million - $11.4 Million	33,133 Added 17.58%	221,623 $70.6 Million
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $930,606 - $1.09 Million	3,310 Added 1.79%	188,490 $59 Million
Q2 2017 Aug 11, 2017	BUY	N/A	185,180	185,180 $50.3 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Biogen Inc. Transaction History